Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease

Arthritis Research and Therapy

Volumn 5, Issue 1, 2003, Pages 25-27

  Crofford, Leslie J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Aspirin; Asthma; Cyclooxygenase inhibitors; Non steroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; LEUKOTRIENE; LEUKOTRIENE RECEPTOR AFFECTING AGENT; MELOXICAM; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; ROFECOXIB; CYCLOOXYGENASE 2; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN;

ARTICLE; ASTHMA; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DRUG CROSS REACTIVITY; DRUG HYPERSENSITIVITY; EOSINOPHIL; HUMAN; LOWER RESPIRATORY TRACT; MAST CELL; NOSE POLYP; PROSTAGLANDIN SYNTHESIS INHIBITION; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; RHINITIS; SINUSITIS; UPPER RESPIRATORY TRACT; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG INTERACTION; EDITORIAL; PHYSIOLOGY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0037625398     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Szczeklik A, Nizankowska E, Duplaga M: Natural history of aspirin-induced asthma. Eur Respir J 2000, 16:432-436.
2. Hedman J, Kaprio J, Poussa T, Nieminen MM: Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999, 28:717-722.
3. Woessner KM, Simon RA, Stevenson DD: The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum 2002, 46:2201-2206.
4. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998, 101:834-846.
5. Demoly P, Jaffuel D, Lequeux N, Weksler B, Creminon C, Michel FB, Godard P, Bousquet J: Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics. Am J Respir Crit Care Med 1997, 155:670-675.
6. Sousa AR, Pfister R, Christie PE, Lane SJ, Nasser SM, Schmitz-Schumann M, Lee TH: Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 1997, 52:940-945.
7. Redington AE, Meng Q-H, Springall, D R, Evans TJ, Creminon C, Maclouf J, Holgate ST, Howarth PH, Polak JM: Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax 2001, 56:351-356.
8. Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M: Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2000, 31:219-225.
9. Dahlen B, Szczeklik A, Murray JJ: Celecoxib in patients with asthma and aspirin intolerance. New Engl J Med 2001, 344: 142.
10. Stevenson DD, Simon RA: Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001, 108:47-51.